演題抄録

ポスター

開催概要
開催回
第56回・2018年・横浜
 

当科における進行再発右側結腸癌に対する全身化学療法施行例の後方視的解析

演題番号 : P17-4

[筆頭演者]
演者)相良 浩輔:1 
[共同演者]
是石 咲耶:1、相川 智美:1、中野 倫孝:1、高吉 琴絵:1、薦田 正人:1、江崎 泰斗:1

1:九州がんセンター・消化管・腫瘍内科

 

Background: Accumulating evidence suggests that colon cancer sideness should be acknowledged as a criterion for establishing prognosis of metastatic colon cancer patients. The prognosis of right sided colon cancer patients is reported to be worse than that of left sided colon cancer patients. We aimed to analyze the therapeutic course of right sided colon cancer patients in clinical practice.
Methods: We retrospectively analyzed the therapeutic course of 77 metastatic right sided colon cancer patients who received systemic chemotherapy between 2013 and 2017 in our hospital.
Results: The patients' performance status (PS) ranged 0 to 2(PS0, 1, 2=34, 38, 5 patients, respectively ). The median progression free survival (PFS) was 7.5 months (95% CI 5.4-9.6 months), and the median overall survival (OS) was 17.5 months (95% CI 14.5-20.1 months). Many patients tended to have aggressive clinical courses after they experienced disease progression.
Conclusion: In clinical practice, right sided colon cancer patients tend to have a relatively short PFS and OS than those reported in clinical trials.

キーワード

臓器別:大腸・小腸

手法別:化学療法

前へ戻る